Compile Data Set for Download or QSAR
maximum 50k data
Found 423 with Last Name = 'halcomb' and Initial = 'rl'
TargetBeta-galactoside alpha-2,6-sialyltransferase 1(Rattus norvegicus)
University Of Colorado

Curated by ChEMBL
LigandPNGBDBM50310540(((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)...)
Affinity DataKi:  6.40E+4nMAssay Description:Inhibitory activity evaluated against alpha-2,6-sialyltransferase from rat liverMore data for this Ligand-Target Pair
TargetCMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase(Rattus norvegicus)
University Of Colorado

Curated by ChEMBL
LigandPNGBDBM50310540(((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)...)
Affinity DataKi:  6.50E+4nMAssay Description:Inhibitory activity evaluated against alpha-2,3-sialyltransferase from rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase(Rattus norvegicus)
University Of Colorado

Curated by ChEMBL
LigandPNGBDBM50366833(CHEMBL608928)
Affinity DataKi:  3.00E+5nMAssay Description:Inhibitory activity evaluated against alpha-2,3-sialyltransferase from rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-galactoside alpha-2,6-sialyltransferase 1(Rattus norvegicus)
University Of Colorado

Curated by ChEMBL
LigandPNGBDBM50366837(CHEMBL608619)
Affinity DataKi:  3.70E+5nMAssay Description:Inhibitory activity evaluated against alpha-2,6-sialyltransferase from rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase(Rattus norvegicus)
University Of Colorado

Curated by ChEMBL
LigandPNGBDBM50366837(CHEMBL608619)
Affinity DataKi:  7.10E+5nMAssay Description:Inhibitory activity evaluated against alpha-2,3-sialyltransferase from rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-galactoside alpha-2,6-sialyltransferase 1(Rattus norvegicus)
University Of Colorado

Curated by ChEMBL
LigandPNGBDBM50366833(CHEMBL608928)
Affinity DataKi:  7.30E+5nMAssay Description:Inhibitory activity evaluated against alpha-2,6-sialyltransferase from rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase(Rattus norvegicus)
University Of Colorado

Curated by ChEMBL
LigandPNGBDBM50366832(CHEMBL609516)
Affinity DataKi:  9.00E+5nMAssay Description:Inhibitory activity evaluated against alpha-2,3-sialyltransferase from rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-galactoside alpha-2,6-sialyltransferase 1(Rattus norvegicus)
University Of Colorado

Curated by ChEMBL
LigandPNGBDBM50366836(CHEMBL610554)
Affinity DataKi:  1.70E+6nMAssay Description:Inhibitory activity evaluated against alpha-2,6-sialyltransferase from rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-galactoside alpha-2,6-sialyltransferase 1(Rattus norvegicus)
University Of Colorado

Curated by ChEMBL
LigandPNGBDBM50366835(CHEMBL609514)
Affinity DataKi:  2.20E+6nMAssay Description:Inhibitory activity evaluated against alpha-2,6-sialyltransferase from rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase(Rattus norvegicus)
University Of Colorado

Curated by ChEMBL
LigandPNGBDBM50366836(CHEMBL610554)
Affinity DataKi:  2.30E+6nMAssay Description:Inhibitory activity evaluated against alpha-2,3-sialyltransferase from rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase(Rattus norvegicus)
University Of Colorado

Curated by ChEMBL
LigandPNGBDBM50366834(CHEMBL609800)
Affinity DataKi:  2.30E+6nMAssay Description:Inhibitory activity evaluated against alpha-2,3-sialyltransferase from rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-galactoside alpha-2,6-sialyltransferase 1(Rattus norvegicus)
University Of Colorado

Curated by ChEMBL
LigandPNGBDBM50366838(CHEMBL609215)
Affinity DataKi:  2.40E+6nMAssay Description:Inhibitory activity evaluated against alpha-2,6-sialyltransferase from rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-galactoside alpha-2,6-sialyltransferase 1(Rattus norvegicus)
University Of Colorado

Curated by ChEMBL
LigandPNGBDBM50366832(CHEMBL609516)
Affinity DataKi:  2.50E+6nMAssay Description:Inhibitory activity evaluated against alpha-2,6-sialyltransferase from rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-galactoside alpha-2,6-sialyltransferase 1(Rattus norvegicus)
University Of Colorado

Curated by ChEMBL
LigandPNGBDBM50366834(CHEMBL609800)
Affinity DataKi:  3.80E+6nMAssay Description:Inhibitory activity evaluated against alpha-2,6-sialyltransferase from rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase(Rattus norvegicus)
University Of Colorado

Curated by ChEMBL
LigandPNGBDBM50366835(CHEMBL609514)
Affinity DataKi:  5.10E+6nMAssay Description:Inhibitory activity evaluated against alpha-2,3-sialyltransferase from rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase(Rattus norvegicus)
University Of Colorado

Curated by ChEMBL
LigandPNGBDBM50366838(CHEMBL609215)
Affinity DataKi:  5.30E+6nMAssay Description:Inhibitory activity evaluated against alpha-2,3-sialyltransferase from rat liverMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 7(Homo sapiens (Human))
Terns Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50088301((E)-N,N-dimethyl-N-(4-(2-p-tolyl-6,7-dihydro-5H-be...)
Affinity DataIC50:  1.40nMAssay Description:Inhibition of CCR7 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetyl-CoA carboxylase 1(Homo sapiens (Human))
Terns Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50069756(CHEMBL3407547 | Firsocostat | ND-630 | NDI-010976 ...)
Affinity DataIC50:  1.70nMAssay Description:Inhibition of ACC1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetyl-CoA carboxylase 2(Homo sapiens (Human))
Terns Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50069756(CHEMBL3407547 | Firsocostat | ND-630 | NDI-010976 ...)
Affinity DataIC50:  2.60nMAssay Description:Inhibition of ACC2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetyl-CoA carboxylase 1(Homo sapiens (Human))
Terns Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50511117(CHEMBL4557289)
Affinity DataIC50:  3nMAssay Description:Inhibition of ACC1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetyl-CoA carboxylase 2(Homo sapiens (Human))
Terns Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50511117(CHEMBL4557289)
Affinity DataIC50:  3nMAssay Description:Inhibition of ACC2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 7(Homo sapiens (Human))
Terns Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50306033(Cenicriviroc | TAK-652 | TBR-652)
Affinity DataIC50:  3.10nMAssay Description:Inhibition of CCR7 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Terns Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50306033(Cenicriviroc | TAK-652 | TBR-652)
Affinity DataIC50:  5.90nMAssay Description:Inhibition of CCR2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetKetohexokinase(Homo sapiens (Human))
Terns Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM319585(US10174007, Example 4 | US10787438, Example 4 | US...)
Affinity DataIC50:  14nMAssay Description:Inhibition of recombinant His-tagged human KHK expressed in Escherichia coli in presence of NADPHMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDiacylglycerol O-acyltransferase 2(Homo sapiens (Human))
Terns Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50511118(CHEMBL4456029)
Affinity DataIC50:  17nMAssay Description:Inhibition of recombinant FLAG-tagged human DGAT2 expressed in SF9 cells after 1 hr by TopCount assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Terns Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50088301((E)-N,N-dimethyl-N-(4-(2-p-tolyl-6,7-dihydro-5H-be...)
Affinity DataIC50:  27nMAssay Description:Inhibition of CCR2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetyl-CoA carboxylase 2(Homo sapiens (Human))
Terns Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50511112(CHEMBL4567446)
Affinity DataIC50:  30nMAssay Description:Inhibition of ACC2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetyl-CoA carboxylase 1(Homo sapiens (Human))
Terns Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50511112(CHEMBL4567446)
Affinity DataIC50:  31nMAssay Description:Inhibition of ACC1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448736((R)-2-pivalamido-4-((R)-3-(2-(5,6,7,8- | US1069667...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448743((S)-2-((tert-butoxycarbonyl)amino)-4- | US10696672...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448745((S)-2-benzamido-4-((R)-3-(2-(5,6,7,8- | US10696672...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448745((S)-2-benzamido-4-((R)-3-(2-(5,6,7,8- | US10696672...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448757((S)-2-(2,6-dimethylbenzamido)-4-((R)- | US10696672...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448759((R)-2-(2,6-dimethylbenzamido)-4-((R)- | US10696672...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448760((S)-2-(2-chloro-3-fluorobenzamido)-4- | US10696672...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448761((S)-2-(2,6-dichlorobenzamido)-4-((R)- | US10696672...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448766(US10696672, Compound 7a | US11634418, Compound 7a)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448767(US10696672, Compound 7c | US11634418, Compound 7c)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448768((S)-4-((R)-3-(2-(5,6,7,8-tetrahydro-1,8- | US10696...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448771((S)-4-((R)-3-(2-(5,6,7,8-tetrahydro-1,8- | US10696...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448772((S)-4-((R)-3-(2-(5,6,7,8-tetrahydro-1,8- | US10696...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448774((S)-2-(2,6-dichlorobenzamido)-4-((R)- | US10696672...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448776((S)-2-(3-(3,5-dimethyl-1H-pyrazol-1- | US10696672,...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448777((R)-2-(3-(3,5-dimethyl-1H-pyrazol-1- | US10696672,...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448776((S)-2-(3-(3,5-dimethyl-1H-pyrazol-1- | US10696672,...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448777((R)-2-(3-(3,5-dimethyl-1H-pyrazol-1- | US10696672,...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448779((S)-2-(3-morpholinobenzamido)-4- | US10696672, Com...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448782((S)-2-(isonicotinamido)-4-((R)-3-(2- | US10696672,...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448784((S)-2-(3,5-dichloroisonicotinamido)-4- | US1069667...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Pliant Therapeutics

US Patent
LigandPNGBDBM448785((R)-2-(3,5-dichloroisonicotinamido)-4- | US1069667...)
Affinity DataIC50: <50nMAssay Description:Microplates were coated with recombinant human integrin αvβ6 (2 ug/ml) in PBS (100 ul/well 25° C., overnight). The coating solution was rem...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 423 total ) | Next | Last >>
Jump to: